Airbus Is Not a Cyclical — It's a $1 Trillion Toll Road the Market Keeps Misreading

When Airbus released its July delivery numbers alongside another round of multi-billion-dollar orders from Chinese carriers, the headlines settled on a safe summary: "stable deliveries, confirms China orders."

Stable is the kind of word that makes you put the article down and check your phone. But it misses what's actually happening.

This is not a story about a cyclical company putting in a decent month. This is a story about one of the most structurally powerful duopolies in the global economy, sitting on a backlog valued at over $1 trillion, with pricing power so entrenched that Chinese state-owned airlines are booking 95 aircraft worth $17.8 billion without negotiation. That is not cyclical demand. That is the aviation industry's version of a toll road, and I believe the market is still pricing it like a manufacturing business that could go out of style.

The deliveries that matter — and what they actually show

Airbus delivered 351 commercial aircraft in the first half of 2026, up from 306 in the same period a year earlier. The second quarter was the real story: after a brutal Q1 that was dragged down by Pratt & Whitney engine shortages, Airbus delivered roughly 237 aircraft in Q2 alone. Revenue jumped 12% to €33.2 billion. Adjusted EBIT — earnings before interest and taxes, excluding restructuring and currency impacts, the metric Airbus uses as its core profitability gauge — rose 24% to €2.7 billion. Q2 adjusted EBIT was €2.43 billion, a 54% increase year-on-year that beat analyst expectations of €2.19 billion.

What does that tell you? It tells you that Airbus is a business where deliveries are supply-constrained, not demand-constrained. The company is not fighting to find customers. It is fighting to build enough planes to fill a backlog of 16,683 aircraft — roughly 10.6 years of production at its current annual target of 870 deliveries.

That is the exact opposite of the cyclical manufacturing business most investors imagine when they hear "aircraft maker."

The China orders are not a one-off — they are a structural proof point

In July alone, three major Chinese state-owned airlines — Air China, Shenzhen Airlines, and Hainan Airlines — ordered 95 Airbus aircraft worth $17.8 billion. Earlier in the month, China Eastern added 25 A330neo widebody jets with a list price of roughly €9.35 billion, to be delivered between 2029 and 2033. That follows China Eastern's March 2026 deal for 101 A320neo narrowbody jets worth $15.8 billion.

This is significant for two reasons. First, these orders are being booked for delivery five to seven years out. Airlines are not ordering on a whim. They are locking in capacity they expect to need well into the next decade. Second, this is happening in a market where China's own COMAC C919 program is still seeking European certification — a certification process that Airbus briefly held up as leverage earlier this year. The fact that Chinese airlines are continuing to load up on Airbus despite the geopolitical friction and domestic alternatives tells you something about competitive moats.

You cannot replicate a certified commercial airliner program in a generation. No one has launched a credible widebody competitor in decades. That is pricing power.

The balance sheet is doing the heavy lifting

Here is where the story gets better for investors who care about downside protection. At the end of June 2026, Airbus held €23.4 billion in gross cash and a net cash position of €8.4 billion. That is lower than the €12.2 billion net cash position at year-end 2025, but the drawdown reflects a planned inventory build to support production ramp-ups — not operational weakness.

Free cash flow before customer financing was negative €1.2 billion in H1, an improvement from negative €1.6 billion in the prior-year period. The company is investing cash to build inventory so it can deliver on its production targets. Full-year guidance calls for approximately €4.5 billion in free cash flow before customer financing, which would comfortably support the proposed €3.20 per-share dividend.

That dividend is a key detail. The €3.20 payout represents a significant increase from the prior year's €2.25 per share (when Airbus delivered 793 aircraft on €73.4 billion in revenue with €6.61 in EPS). The stock trades at roughly 20 times trailing earnings, with a dividend yield around 1.5%. That is not an income stock. This is a dividend-growth compounder. And from a compounding perspective, the question is not whether 1.5% satisfies your income needs today. The question is whether a company with this kind of delivery growth trajectory, pricing power, and balance sheet can double or triple that yield on cost over the next decade without cutting the payout.

The duopoly advantage — and why it matters more in an inflationary regime

I don't think the common understanding of Airbus as a "cyclical" holds up when you look at the actual mechanics of the business. Airbus and Boeing together control the entire market for large commercial aircraft. There are no credible alternatives. When airlines need to replace aging fleets, expand capacity, or modernize for fuel efficiency, there are exactly two vendors.

That oligopolistic structure is what gives Airbus its pricing power. The July orders from Chinese airlines were written at list prices. A $17.8 billion deal for 95 aircraft is not a deeply discounted volume transaction. It is close to what the catalogue says.

This is the kind of structural advantage that matters most in an inflationary regime. I believe inflation is likely to remain more persistent than the market's baseline wants to admit — structural forces around deglobalization, energy transition, supply-chain reconfiguration, and fiscal dominance all point toward a higher average. In that environment, companies that can raise prices without losing customers are the ones that protect your purchasing power.

Airbus is one of those companies.

The valuation question

At roughly 20 times trailing earnings and a market capitalization near €170 billion, Airbus is not cheap. The stock has run significantly over the past year as delivery momentum returned and Q2 results removed first-quarter concerns. A 20x multiple is not unreasonable for a business with this growth trajectory and competitive position, but it does mean the stock is not offering a margin of safety that would excite deep-value investors.

What makes the valuation defensible is the visibility. With 9,222 aircraft in the backlog, Airbus has roughly 10.6 years of production fully contracted. Revenue is not a question mark. The bigger risk is execution: can the company hit its delivery targets of around 870 for 2026 and then ramp to higher rates on the A320 family (70–75 per month by end of 2027) and A350 (12 per month by 2028)? Q2's strong performance suggests the answer is yes, but the Pratt & Whitney engine shortage earlier this year reminds you that supply chain risk is real.

Boeing, meanwhile, remains in damage-control mode. Through June 2026, Boeing delivered 314 aircraft versus Airbus's 351, and logged 445 gross orders compared to Airbus's 886 — less than half. Boeing's commercial operation remains loss-making, its 737 MAX production is capped by the FAA at 42 per month, and it is drawing down built inventory of 787 Dreamliners to sustain delivery volumes. The duopoly is not symmetrical.

The real question for the reader

Airbus is not a stock you buy for yield. At around 1.5%, the current payout will not move the needle in a retirement-income portfolio. This is not a stock I would treat as an income shortcut.

This is a stock that belongs in the income-growth sleeve — the part of the portfolio where you accept a modest current yield in exchange for a payout that compounds because the underlying business can grow earnings power without fighting for market share. A company that delivers 870-plus aircraft per year on a $1 trillion backlog, raises dividends as throughput increases, and operates in an industry where there are exactly two players and no credible entrant — that is the structural setup.

The July delivery numbers and the China orders are not headline events. They are data points in a trend that has been building for two years. The market keeps calling Airbus a cyclical because it makes an aircraft. But the aircraft industry is not a commodity. It is a capital-intensive, highly regulated, irreproducible duopoly with more pricing power than most investors give it credit for.

If you own Airbus, the question is not whether the stock is cheap. The question is whether you understand the business well enough to hold it through cycles, supply hiccups, and geopolitical noise — and whether you can tolerate a valuation that already reflects a good portion of the growth that's coming.